Valuation: MicroPort CardioFlow Medtech Corporation

Capitalization 1.74B 2.01B 257M 222M 204M 192M 358M 24.47B 363M 2.43B 944M 11.83B 964M 943M 41.15B P/E ratio 2026 *
-102x
P/E ratio 2027 * -305x
Enterprise value 1.74B 2.01B 257M 222M 204M 192M 358M 24.47B 363M 2.43B 944M 11.83B 964M 943M 41.15B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.34x
Free-Float
42.4%
Yield 2026 *
-
Yield 2027 * -
1 day-2.47%
1 week-4.82%
Current month-4.82%
1 month-33.61%
3 months-54.99%
6 months-73.22%
Current year-73.88%
1 week 1.56
Extreme 1.56
1.73
1 month 1.56
Extreme 1.56
2.46
Current year 1.56
Extreme 1.56
6.4
1 year 1.56
Extreme 1.56
8.45
3 years 1.56
Extreme 1.56
12.45
5 years 1.56
Extreme 1.56
86.5
10 years 1.56
Extreme 1.56
111
Manager TitleAgeSince
Director of Finance/CFO 40 31/07/2024
President 62 26/03/2025
Chief Tech/Sci/R&D Officer 41 31/01/2024
Director TitleAgeSince
Chairman 41 28/08/2023
Director/Board Member 45 04/08/2019
Director/Board Member 62 14/01/2021
Date Insider Type Main position Quantity % Market Cap.
04-21Other

Director

400,000 0.0314%
04-20Other

Director

339,000 0.0266%
03-30Other

Chairperson

143,920 0.0023%
Change 5d. change 1-year change 3-years change Capi.($)
-2.47%-4.82%-63.68%-82.05% 257M
+1.48%+0.19%-20.38%+10.53% 117B
+1.28%+3.24%+2.00%-5.95% 13.1B
+2.72%+20.95%+34.42%+92.84% 7.34B
+1.21%-5.60%-42.85%-69.20% 4.4B
+1.43%-0.27%+6.25%+22.62% 2.44B
-0.69%-3.47%+12.78%-4.92% 1.76B
+0.24%-2.85%-26.82%-22.54% 1.63B
+3.45%+0.15% - - 1.39B
Average +0.96%+0.75%-12.29%-7.33% 16.61B
Weighted average by Cap. +1.49%+1.21%-15.66%+10.27%

Financials

2026 *2027 *
Net sales 300M 347M 44.3M 38.37M 35.21M 33.12M 61.69M 4.22B 62.66M 418M 163M 2.04B 166M 163M 7.1B 326M 377M 48.07M 41.63M 38.2M 35.94M 66.93M 4.58B 67.98M 454M 177M 2.22B 180M 177M 7.7B
Net income -17.03M -19.69M -2.51M -2.18M -2M -1.88M -3.5M -240M -3.55M -23.74M -9.24M -116M -9.44M -9.23M -403M -5.7M -6.6M -842K -729K -669K -629K -1.17M -80.21M -1.19M -7.95M -3.09M -38.79M -3.16M -3.09M -135M
Net Debt - -
Logo MicroPort CardioFlow Medtech Corporation
Microport Cardioflow Medtech Corp is a medical device company primarily engaged in the provision of total solutions to physicians and patients for the treatment of structural heart diseases. The Company’s main business is engaged in the research and development and commercialization of transcatheter and surgical solutions for structural heart diseases. The Company’s pipelines include VitaFlow, VitaFlow Liberty (including procedural accessories as supporting supply), VitaFlow Liberty Flex, Alwide Plus, AccuSnipe, AnchorMan LAAC System and AnchorMan LAAA System, and transcatheter aortic heart valve implantation (TAVI) products, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products, left atrial appendage (LAA) products and procedural accessories at different development stages. The Company conducts its business in the domestic and overseas markets.
Employees
1,415
Date Price Change Volume
05/06/26 1.580 $ -2.47% 924,800
04/06/26 1.620 $ -2.99% 884,407
03/06/26 1.670 $ -0.60% 922,000
02/06/26 1.680 $ -0.59% 564,600
01/06/26 1.690 $ +1.81% 1,282,021
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.366CNY
Average target price
6.108CNY
Spread / Average Target
+347.10%

Annual profits - Rate of surprise